Market Tracker

12/07 5:10pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.08
Delayed Data
As of 4:02pm ET
 -0.55 / -3.52%
Today’s Change
13.77
Today|||52-Week Range
119.87
-85.16%
Year-to-Date
Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump
12:29pm / Zacks.com - Paid Partner Content
Surprise! The SEC Isn't Happy With Valeant Pharmaceuticals Again
Dec 05 / MotleyFool.com - Paid Partner Content
Trump warns Wall Street: I'm going to cut drug prices
10:40am / CNNMoney.com
3 Prime Reasons Valeant Pharmaceuticals Intl. Inc. Shares Dove 11% in November
Dec 05 / MotleyFool.com - Paid Partner Content
24 Questions With Value Investor Jacob Taylor of the UC Davis Graduate School of Mana...
Dec 06 / GuruFocus News - Paid Partner Content
Is Mylan Being Really Smart -- Or Really Arrogant?
Dec 04 / MotleyFool.com - Paid Partner Content
Questions Mount at Teva Amid C-suite Change
Dec 06 / TheStreet.com - Paid Partner Content
3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November
Dec 06 / MotleyFool.com - Paid Partner Content
Frontrunning: December 1
Dec 01 / Investing Channel - Paid Partner Content

Today’s Trading

Previous close15.63
Today’s open15.42
Day’s range14.82 - 15.43
Volume19,244,074
Average volume (3 months)22,239,692
Market cap$5.3B
Dividend yield--
Data as of 4:02pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-46.13%
Earnings growth (next 5 years)+9.80%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book0.91

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-2.36-4.39%
IONSIonis Pharmaceutical...-1.45-3.06%
UTHRUnited Therapeutics ...-5.22-3.82%
JAZZJazz Pharmaceuticals...-3.28-3.16%
Data as of 4:03pm ET, 12/07/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts